|
|
|
|
LEADER |
03027nam a22003495i 4500 |
001 |
000284416 |
005 |
20210817145028.0 |
007 |
cr nn 008mamaa |
008 |
150326s2015 ja | s |||| 0|eng d |
020 |
|
|
|a 9784431553274
|
024 |
7 |
|
|a 10.1007/978-4-431-55327-4
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Inflammation and Immunity in Cancer /
|c edited by Tsukasa Seya, Misako Matsumoto, Keiko Udaka, Noriyuki Sato.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Tokyo :
|b Springer Japan :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a XI, 268 p. 72 illus., 60 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Preface -- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis.- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis -- 3 Regulation of tumor-associated myeloid cells by innate immune signaling -- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses -- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways -- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells -- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation -- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus.- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells -- 10 Development of immunotherapy for hepatocellular carcinoma -- 11 Development of glypican-3-targeted cancer immunotherapy -- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation -- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy -- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models -- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy -- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects -- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression -- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench -- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC) -- 20 Overview on tumor immunology.-BM Epilogue.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Oncology .
|
650 |
1 |
4 |
|a Immunology.
|
650 |
2 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Oncology.
|
700 |
1 |
|
|a Seya, Tsukasa.
|e editor.
|
700 |
1 |
|
|a Matsumoto, Misako.
|e editor.
|
700 |
1 |
|
|a Udaka, Keiko.
|e editor.
|
700 |
1 |
|
|a Sato, Noriyuki.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|